Characterization and receptor specific toxicity of two diphtheria toxin‐related interleukin‐3 fusion proteins DAB389–mIL‐3 and DAB389–(Gly4Ser)2‐mIL‐3

We have constructed two fusion proteins, DAB389–mIL‐3 and DAB389‐(Gly4Ser)2–mIL‐3, in which the receptor‐binding domain of diphtheria toxin is replaced by mouse interleukin‐3 (IL‐3). Cytotoxic activity of the fusion toxins was observed on three out of six cell lines assayed. This toxicity was mediat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:FEBS letters 1997-04, Vol.406 (1-2), p.157-161
Hauptverfasser: Liger, Dominique, vanderSpek, Johanna C, Gaillard, Carole, Cansier, Christophe, Murphy, John R, Leboulch, Philippe, Gillet, Daniel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 161
container_issue 1-2
container_start_page 157
container_title FEBS letters
container_volume 406
creator Liger, Dominique
vanderSpek, Johanna C
Gaillard, Carole
Cansier, Christophe
Murphy, John R
Leboulch, Philippe
Gillet, Daniel
description We have constructed two fusion proteins, DAB389–mIL‐3 and DAB389‐(Gly4Ser)2–mIL‐3, in which the receptor‐binding domain of diphtheria toxin is replaced by mouse interleukin‐3 (IL‐3). Cytotoxic activity of the fusion toxins was observed on three out of six cell lines assayed. This toxicity was mediated through binding to the IL‐3 receptor as it was inhibited in a dose‐dependent manner with murine IL‐3 or anti‐IL‐3 neutralizing antibodies. DAB389–(Gly4Ser)2‐mIL‐3 was up to 5 times more toxic than DAB389–mIL‐3, depending on the cell line (0.8×10−10 M
doi_str_mv 10.1016/S0014-5793(97)00243-3
format Article
fullrecord <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmed_primary_9109408</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>FEB2S0014579397002433</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2333-14aedf048682c4c8cab05b65e09098efb3f235eb3a387730d83b3a4c8f8fd7473</originalsourceid><addsrcrecordid>eNo9kU1OwzAUhC0EgvJzBCQvyyJg57m1vWzLTytVYgGsLSexVUOaRI6rUlYcAYkrcLKehCStuvLzfOOx9Aaha0puKaHDuxdCKIsGXEJf8htCYgYRHKEeFbwZ2FAco97BcobO6_qdNHdB5Sk6lZRIRkQP_U0W2us0GO--dHBlgXWRYW9SU4XS47oyqbMuxaH8dKkLG1xaHNYlzly1CIvmle5Qsf3-8SbXwWTYFU1ablYfnQrYruo2t_JlMK6o8f1oDEJuv3-Xs3lnaH88iP2nfMNejL-JG7Z3XKITq_PaXO3PC_T2-PA6mUbz56fZZDSPqhgAIsq0ySxhYijilKUi1QkZJMOBIZJIYWwCNoaBSUCD4BxIJqCZG6MVNuOMwwW63uVWq2RpMlV5t9R-o_bbavh0x9cuN5sDpkS1jaiuEdWuW0muukYUqMeHcdyRFkjeyQD_zG2Ixw</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Characterization and receptor specific toxicity of two diphtheria toxin‐related interleukin‐3 fusion proteins DAB389–mIL‐3 and DAB389–(Gly4Ser)2‐mIL‐3</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>Wiley Online Library Free Content</source><source>Wiley Online Library All Journals</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Liger, Dominique ; vanderSpek, Johanna C ; Gaillard, Carole ; Cansier, Christophe ; Murphy, John R ; Leboulch, Philippe ; Gillet, Daniel</creator><creatorcontrib>Liger, Dominique ; vanderSpek, Johanna C ; Gaillard, Carole ; Cansier, Christophe ; Murphy, John R ; Leboulch, Philippe ; Gillet, Daniel</creatorcontrib><description>We have constructed two fusion proteins, DAB389–mIL‐3 and DAB389‐(Gly4Ser)2–mIL‐3, in which the receptor‐binding domain of diphtheria toxin is replaced by mouse interleukin‐3 (IL‐3). Cytotoxic activity of the fusion toxins was observed on three out of six cell lines assayed. This toxicity was mediated through binding to the IL‐3 receptor as it was inhibited in a dose‐dependent manner with murine IL‐3 or anti‐IL‐3 neutralizing antibodies. DAB389–(Gly4Ser)2‐mIL‐3 was up to 5 times more toxic than DAB389–mIL‐3, depending on the cell line (0.8×10−10 M&lt;IC50&lt;3×10−10 M). These proteins can be used for the detection of IL‐3 receptors on mouse cells and should allow for the selective elimination of IL‐3 receptor‐positive pluripotent hematopoietic stem cells prior to bone marrow transplantation.</description><identifier>ISSN: 0014-5793</identifier><identifier>EISSN: 1873-3468</identifier><identifier>DOI: 10.1016/S0014-5793(97)00243-3</identifier><identifier>PMID: 9109408</identifier><language>eng</language><publisher>England</publisher><subject>Animals ; Cell Line ; Cell Survival - drug effects ; Diphtheria toxin ; Diphtheria Toxin - chemistry ; Diphtheria Toxin - metabolism ; Diphtheria Toxin - toxicity ; Fusion toxin ; Interleukin-2 - chemistry ; Interleukin-2 - metabolism ; Interleukin-2 - toxicity ; Interleukin-3 ; Interleukin-3 - chemistry ; Interleukin-3 - metabolism ; Interleukin-3 - toxicity ; Mice ; Protein Folding ; Receptor targeting ; Receptors, Interleukin-3 - drug effects ; Receptors, Interleukin-3 - metabolism ; Recombinant Fusion Proteins - chemistry ; Recombinant Fusion Proteins - metabolism ; Recombinant Fusion Proteins - toxicity</subject><ispartof>FEBS letters, 1997-04, Vol.406 (1-2), p.157-161</ispartof><rights>FEBS Letters 406 (1997) 1873-3468 © 2015 Federation of European Biochemical Societies</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1016%2FS0014-5793%2897%2900243-3$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1016%2FS0014-5793%2897%2900243-3$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,1434,27928,27929,45578,45579,46413,46837</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9109408$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liger, Dominique</creatorcontrib><creatorcontrib>vanderSpek, Johanna C</creatorcontrib><creatorcontrib>Gaillard, Carole</creatorcontrib><creatorcontrib>Cansier, Christophe</creatorcontrib><creatorcontrib>Murphy, John R</creatorcontrib><creatorcontrib>Leboulch, Philippe</creatorcontrib><creatorcontrib>Gillet, Daniel</creatorcontrib><title>Characterization and receptor specific toxicity of two diphtheria toxin‐related interleukin‐3 fusion proteins DAB389–mIL‐3 and DAB389–(Gly4Ser)2‐mIL‐3</title><title>FEBS letters</title><addtitle>FEBS Lett</addtitle><description>We have constructed two fusion proteins, DAB389–mIL‐3 and DAB389‐(Gly4Ser)2–mIL‐3, in which the receptor‐binding domain of diphtheria toxin is replaced by mouse interleukin‐3 (IL‐3). Cytotoxic activity of the fusion toxins was observed on three out of six cell lines assayed. This toxicity was mediated through binding to the IL‐3 receptor as it was inhibited in a dose‐dependent manner with murine IL‐3 or anti‐IL‐3 neutralizing antibodies. DAB389–(Gly4Ser)2‐mIL‐3 was up to 5 times more toxic than DAB389–mIL‐3, depending on the cell line (0.8×10−10 M&lt;IC50&lt;3×10−10 M). These proteins can be used for the detection of IL‐3 receptors on mouse cells and should allow for the selective elimination of IL‐3 receptor‐positive pluripotent hematopoietic stem cells prior to bone marrow transplantation.</description><subject>Animals</subject><subject>Cell Line</subject><subject>Cell Survival - drug effects</subject><subject>Diphtheria toxin</subject><subject>Diphtheria Toxin - chemistry</subject><subject>Diphtheria Toxin - metabolism</subject><subject>Diphtheria Toxin - toxicity</subject><subject>Fusion toxin</subject><subject>Interleukin-2 - chemistry</subject><subject>Interleukin-2 - metabolism</subject><subject>Interleukin-2 - toxicity</subject><subject>Interleukin-3</subject><subject>Interleukin-3 - chemistry</subject><subject>Interleukin-3 - metabolism</subject><subject>Interleukin-3 - toxicity</subject><subject>Mice</subject><subject>Protein Folding</subject><subject>Receptor targeting</subject><subject>Receptors, Interleukin-3 - drug effects</subject><subject>Receptors, Interleukin-3 - metabolism</subject><subject>Recombinant Fusion Proteins - chemistry</subject><subject>Recombinant Fusion Proteins - metabolism</subject><subject>Recombinant Fusion Proteins - toxicity</subject><issn>0014-5793</issn><issn>1873-3468</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kU1OwzAUhC0EgvJzBCQvyyJg57m1vWzLTytVYgGsLSexVUOaRI6rUlYcAYkrcLKehCStuvLzfOOx9Aaha0puKaHDuxdCKIsGXEJf8htCYgYRHKEeFbwZ2FAco97BcobO6_qdNHdB5Sk6lZRIRkQP_U0W2us0GO--dHBlgXWRYW9SU4XS47oyqbMuxaH8dKkLG1xaHNYlzly1CIvmle5Qsf3-8SbXwWTYFU1ablYfnQrYruo2t_JlMK6o8f1oDEJuv3-Xs3lnaH88iP2nfMNejL-JG7Z3XKITq_PaXO3PC_T2-PA6mUbz56fZZDSPqhgAIsq0ySxhYijilKUi1QkZJMOBIZJIYWwCNoaBSUCD4BxIJqCZG6MVNuOMwwW63uVWq2RpMlV5t9R-o_bbavh0x9cuN5sDpkS1jaiuEdWuW0muukYUqMeHcdyRFkjeyQD_zG2Ixw</recordid><startdate>19970407</startdate><enddate>19970407</enddate><creator>Liger, Dominique</creator><creator>vanderSpek, Johanna C</creator><creator>Gaillard, Carole</creator><creator>Cansier, Christophe</creator><creator>Murphy, John R</creator><creator>Leboulch, Philippe</creator><creator>Gillet, Daniel</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>19970407</creationdate><title>Characterization and receptor specific toxicity of two diphtheria toxin‐related interleukin‐3 fusion proteins DAB389–mIL‐3 and DAB389–(Gly4Ser)2‐mIL‐3</title><author>Liger, Dominique ; vanderSpek, Johanna C ; Gaillard, Carole ; Cansier, Christophe ; Murphy, John R ; Leboulch, Philippe ; Gillet, Daniel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2333-14aedf048682c4c8cab05b65e09098efb3f235eb3a387730d83b3a4c8f8fd7473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Animals</topic><topic>Cell Line</topic><topic>Cell Survival - drug effects</topic><topic>Diphtheria toxin</topic><topic>Diphtheria Toxin - chemistry</topic><topic>Diphtheria Toxin - metabolism</topic><topic>Diphtheria Toxin - toxicity</topic><topic>Fusion toxin</topic><topic>Interleukin-2 - chemistry</topic><topic>Interleukin-2 - metabolism</topic><topic>Interleukin-2 - toxicity</topic><topic>Interleukin-3</topic><topic>Interleukin-3 - chemistry</topic><topic>Interleukin-3 - metabolism</topic><topic>Interleukin-3 - toxicity</topic><topic>Mice</topic><topic>Protein Folding</topic><topic>Receptor targeting</topic><topic>Receptors, Interleukin-3 - drug effects</topic><topic>Receptors, Interleukin-3 - metabolism</topic><topic>Recombinant Fusion Proteins - chemistry</topic><topic>Recombinant Fusion Proteins - metabolism</topic><topic>Recombinant Fusion Proteins - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liger, Dominique</creatorcontrib><creatorcontrib>vanderSpek, Johanna C</creatorcontrib><creatorcontrib>Gaillard, Carole</creatorcontrib><creatorcontrib>Cansier, Christophe</creatorcontrib><creatorcontrib>Murphy, John R</creatorcontrib><creatorcontrib>Leboulch, Philippe</creatorcontrib><creatorcontrib>Gillet, Daniel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>FEBS letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liger, Dominique</au><au>vanderSpek, Johanna C</au><au>Gaillard, Carole</au><au>Cansier, Christophe</au><au>Murphy, John R</au><au>Leboulch, Philippe</au><au>Gillet, Daniel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization and receptor specific toxicity of two diphtheria toxin‐related interleukin‐3 fusion proteins DAB389–mIL‐3 and DAB389–(Gly4Ser)2‐mIL‐3</atitle><jtitle>FEBS letters</jtitle><addtitle>FEBS Lett</addtitle><date>1997-04-07</date><risdate>1997</risdate><volume>406</volume><issue>1-2</issue><spage>157</spage><epage>161</epage><pages>157-161</pages><issn>0014-5793</issn><eissn>1873-3468</eissn><abstract>We have constructed two fusion proteins, DAB389–mIL‐3 and DAB389‐(Gly4Ser)2–mIL‐3, in which the receptor‐binding domain of diphtheria toxin is replaced by mouse interleukin‐3 (IL‐3). Cytotoxic activity of the fusion toxins was observed on three out of six cell lines assayed. This toxicity was mediated through binding to the IL‐3 receptor as it was inhibited in a dose‐dependent manner with murine IL‐3 or anti‐IL‐3 neutralizing antibodies. DAB389–(Gly4Ser)2‐mIL‐3 was up to 5 times more toxic than DAB389–mIL‐3, depending on the cell line (0.8×10−10 M&lt;IC50&lt;3×10−10 M). These proteins can be used for the detection of IL‐3 receptors on mouse cells and should allow for the selective elimination of IL‐3 receptor‐positive pluripotent hematopoietic stem cells prior to bone marrow transplantation.</abstract><cop>England</cop><pmid>9109408</pmid><doi>10.1016/S0014-5793(97)00243-3</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0014-5793
ispartof FEBS letters, 1997-04, Vol.406 (1-2), p.157-161
issn 0014-5793
1873-3468
language eng
recordid cdi_pubmed_primary_9109408
source MEDLINE; Access via ScienceDirect (Elsevier); Wiley Online Library Free Content; Wiley Online Library All Journals; Alma/SFX Local Collection; EZB Electronic Journals Library
subjects Animals
Cell Line
Cell Survival - drug effects
Diphtheria toxin
Diphtheria Toxin - chemistry
Diphtheria Toxin - metabolism
Diphtheria Toxin - toxicity
Fusion toxin
Interleukin-2 - chemistry
Interleukin-2 - metabolism
Interleukin-2 - toxicity
Interleukin-3
Interleukin-3 - chemistry
Interleukin-3 - metabolism
Interleukin-3 - toxicity
Mice
Protein Folding
Receptor targeting
Receptors, Interleukin-3 - drug effects
Receptors, Interleukin-3 - metabolism
Recombinant Fusion Proteins - chemistry
Recombinant Fusion Proteins - metabolism
Recombinant Fusion Proteins - toxicity
title Characterization and receptor specific toxicity of two diphtheria toxin‐related interleukin‐3 fusion proteins DAB389–mIL‐3 and DAB389–(Gly4Ser)2‐mIL‐3
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T21%3A39%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20and%20receptor%20specific%20toxicity%20of%20two%20diphtheria%20toxin%E2%80%90related%20interleukin%E2%80%903%20fusion%20proteins%20DAB389%E2%80%93mIL%E2%80%903%20and%20DAB389%E2%80%93(Gly4Ser)2%E2%80%90mIL%E2%80%903&rft.jtitle=FEBS%20letters&rft.au=Liger,%20Dominique&rft.date=1997-04-07&rft.volume=406&rft.issue=1-2&rft.spage=157&rft.epage=161&rft.pages=157-161&rft.issn=0014-5793&rft.eissn=1873-3468&rft_id=info:doi/10.1016/S0014-5793(97)00243-3&rft_dat=%3Cwiley_pubme%3EFEB2S0014579397002433%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/9109408&rfr_iscdi=true